These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2467971)

  • 1. Inhibition of guanidinobenzoatase by a substrate for trypsin-like enzymes.
    Steven FS; Griffin MM; Mangel WF; Maier H; Altmannsberger M
    J Enzyme Inhib; 1988; 2(3):209-14. PubMed ID: 2467971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further inhibition studies on guanidinobenzoatase, a trypsin-like enzyme associated with tumour cells.
    Steven FS; Griffin MM; Wong TL; Yasmin R; Mangel WF
    J Enzyme Inhib; 1987; 1(3):187-201. PubMed ID: 3334244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the activity of a protease associated with cells at the advancing edge of human tumour masses in frozen sections.
    Steven FS; Griffin MM; Maier H; Weidauer H; Mangel WF; Altmannsberger M
    Br J Cancer; 1988 Jul; 58(1):57-60. PubMed ID: 3166893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of guanidinobenzoatase: evidence for multiple forms of this protease on different tumour cells.
    Steven FS; Griffin MM; Freemont AJ; Johnson J
    J Enzyme Inhib; 1988; 2(2):117-27. PubMed ID: 3236068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fluorescent study of ligands for guanidinobenzoatase, a protease associated with tumour cells.
    Steven F; Griffin MM; Williams LA; Feichter G
    Anticancer Res; 1988; 8(6):1179-83. PubMed ID: 3218954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for inhibitors of the cell surface protease guanidinobenzoatase.
    Steven FS; Griffin MM; Wong TL; Itzhaki S
    J Enzyme Inhib; 1986; 1(2):127-37. PubMed ID: 3508910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The status of trypsin-like enzymes in squamous-cell carcinoma of the head and neck region.
    Steven FS; Williams LA; Maier H; Arndt J; Weidauer H; Born A
    J Cancer Res Clin Oncol; 1990; 116(1):57-64. PubMed ID: 2312606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of guanidinobenzoatase and their possible role in cell migration.
    Steven FS; Griffin MM
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():137-43. PubMed ID: 3202961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of fluorescent probes for an enzyme on the surface of tumour cells.
    Steven FS; Griffin MM; Al-Ahmad RK
    J Chromatogr; 1986 Apr; 376():211-9. PubMed ID: 3711193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The design of fluorescent probes which bind to the active centre of guanidinobenzoatase. Application to the location of cells possessing this enzyme.
    Steven FS; Griffin MM; Al-Ahmad RK
    Eur J Biochem; 1985 May; 149(1):35-40. PubMed ID: 2581779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The enzyme capable to cleave trypsin active site titrant as substrate is a carboxylesterase with electrophoretic mobility similar to albumin.
    Tözsér J; Marsalkó TM; Punyiczki M; Elödi P
    Acta Biochim Biophys Hung; 1990; 25(1-2):57-65. PubMed ID: 2130574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of trypsin-like enzymes on cells with rhodamine-aprotinin.
    Steven FS; Griffin MM; Williams LA; Freemont AJ; Maier H; Weidauer H
    J Enzyme Inhib; 1989; 2(4):295-303. PubMed ID: 2470878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of a protease associated with tumour cells and the probable mechanism of regulation of this interaction in vivo.
    Steven FS; Maier H; Arndt J
    J Enzyme Inhib; 1989; 3(2):145-57. PubMed ID: 2489235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of the proteolytic enzyme guanidinobenzoatase in human basal cell carcinoma.
    Steven FS; Maier H; Born A; Weidauer H
    ORL J Otorhinolaryngol Relat Spec; 1989; 51(6):360-4. PubMed ID: 2480560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and purification of a guanidinobenzoatase: a possible marker of human renal carcinoma.
    Poustis-Delpont C; Descomps R; Auberger P; Delque-Bayer P; Sudaka P; Rossi B
    Cancer Res; 1992 Jul; 52(13):3622-8. PubMed ID: 1617634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of inhibitors in the fluorescent staining of benign naevus and malignant melanoma cells with 9-amino acridine and acridine orange.
    Steven FS; Suresh U; Wong TL; Griffin MM
    J Enzyme Inhib; 1987; 1(4):275-87. PubMed ID: 3508914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for cells possessing t-PA like activity in smears obtained from patients with oral squamous cell carcinoma.
    Steven FS; Griffin MM; Zoeller J; Maier H
    Anticancer Res; 1990; 10(4):995-9. PubMed ID: 2116754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of a tumour protease with 3,4-dichloroisocoumarin, pentamidine-isethionate and guanidino derivatives.
    Anees M; Steven FS
    J Enzyme Inhib; 1994; 8(3):213-21. PubMed ID: 7539490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting adriamycin to tumour cells by means of an affinity ligand; a model system for drug delivery.
    Steven FS; Griffin MM; Williams LA; Ali H; Maier H
    Anticancer Res; 1989; 9(1):247-53. PubMed ID: 2705751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of a cell surface protease after cisplatin chemotherapy.
    Steven FS; Zoeller J; Maier H; Born IA
    J Enzyme Inhib; 1991; 5(2):151-64. PubMed ID: 1669443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.